Similarly, Mertk-knockout mice or administering anti-Mertk neutralizing antibodies altered the cellular immune profile, resulting in an inflamed tumor environment with enhanced T-cell infiltration into tumors and improved cytotoxicity [156]. This evidence concerns the gene MERTK and neoplasm.